CLINICAL_TRIALS
trial_result
· 2015-07-24
Clinical Trial Update: Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) [Phase 2]
Summary
A Phase 2 trial of MK0677 for Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED